Fig. 5From: Effect of sofosbuvir plus daclatasvir on virological response and liver function tests as a line of treatment for HCV related cirrhosis (a prospective cohort study)Change in AFP levels during and post-treatment of the studied patients. P value = 0.02; AFP, alpha-fetoproteinBack to article page